Tenet Healthcare (THC) Tops Q2 EPS by 87c, Revenues Miss

Go back to Tenet Healthcare (THC) Tops Q2 EPS by 87c, Revenues Miss

Tenet Reports Second Quarter 2022 Results; Reaffirms 2022 Adjusted EBITDA Outlook

July 21, 2022 4:05 PM EDT

Net income from continuing operations available to common shareholders in Q222 of $38 million versus $120 million in Q221 Consolidated Adjusted EBITDA in Q222 of $843 million versus $834 million in Q221 Q2'22 USPI Adjusted EBITDA grew 15.3 percent over Q2'21 excluding grant income; Same-facility system-wide ambulatory surgical cases decreased 0.9 percent versus Q221 due to the pandemic Diluted earnings per share from continuing operations available to common shareholders in Q222 of $0.35 compared to $1.11 in Q221; Adjusted diluted earnings per share from continuing operations of $1.50 in Q222 compared to $1.59 in Q221 The disruptive... More